Pheno Therapeutics Website
Edinburgh, GB · 2 known investors
Find your way into Pheno Therapeutics Website
252 people in our graph share verified history with the Pheno Therapeutics Website team — schools, employers, funds. One of them is your warm intro.
Alex Rendónunlockedknows Neil Carragher · together at The University of Edinburgh (overlapped)
×7knows the team · via AstraZeneca
×4knows the team · via University of Aberdeen
Pheno Therapeutics is a clinical-stage biotech company developing GPR17 antagonists that target oligodendrocytes to promote brain repair. Its therapeutics address neurodegenerative and demyelinating disorders such as multiple sclerosis, Alzheimer's disease, ALS, Parkinson's disease, and rare leukodystrophies.
Founders & leadership
NC
Neil CarragherinCo-Founder and Management ConsultantNeil Carragher has built a research career combining molecular and cellular biology with advanced imaging techniques to elucidate target biology and drug mechanisms. He has implemented technology platforms and phenotypic-driven discovery strategies across pharmaceutical and biopharmaceutical organizations, with expertise in disease modeling, in vitro/in vivo imaging, high-content phenotypic analysis, and biomarker discovery.
Investors · 2
Frequently asked questions
- What does Pheno Therapeutics Website do?
- Pheno Therapeutics is a clinical-stage biotech company developing GPR17 antagonists that target oligodendrocytes to promote brain repair. Its therapeutics address neurodegenerative and demyelinating disorders such as multiple sclerosis, Alzheimer's disease, ALS, Parkinson's disease, and rare leukodystrophies.
- Who founded Pheno Therapeutics Website?
- Pheno Therapeutics Website was founded by Neil Carragher.
- Who are Pheno Therapeutics Website's investors?
- Pheno Therapeutics Website's investors include Advent Life Sciences, LifeArc Ventures.
- Where is Pheno Therapeutics Website headquartered?
- Pheno Therapeutics Website is headquartered in Edinburgh, GB.